Translating genomics information into therapeutics: A key role for oligonucleotides (original) (raw)

Subscribe to this journal

Receive 12 print issues and online access

$259.00 per year

only $21.58 per issue

Buy this article

• Purchase on SpringerLink
• Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

1. CEO and president of Ribozyme Pharmaceuticals, 2950 Wilderness Place, Boulder, CO, 80301
   Ralph E. Christoffersen

Authors

1. Ralph E. Christoffersen

Rights and permissions

About this article

Cite this article

Christoffersen, R. Translating genomics information into therapeutics: A key role for oligonucleotides.Nat Biotechnol 15, 483–484 (1997). https://doi.org/10.1038/nbt0697-483

Download citation

• Issue date: 01 June 1997
• DOI: https://doi.org/10.1038/nbt0697-483